Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort studyErica A. Voss, Rohit Vashisht, Anthony G. Sena et al.|EClinicalMedicine|2023Cited by 27
Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network StudyOskar Gauffin, G. Niklas Norén, Milan Lazarević et al.|Drug Safety|2023Cited by 19